EL7.AI
StocksMediumUpdated•Originally published 16 April 2026•Updated 17 April 2026•
1 min read

Kisses from Italy Unveils 2026 Expansion Strategy and Appoints New CEO

Key Facts

1Kisses from Italy announced a 2026 expansion strategy following its business combination with Regen Health Physicians.
2Dr. MD Ajit Dhaliwa was appointed as the new CEO to lead the biologics and longevity sector initiatives.
3The move marks the company's transformative entry into the high-growth biologics and longevity sector.

Kisses from Italy Inc. (KITL), which trades on the OTC Pink market, has detailed its 2026 expansion strategy following its strategic combination with Regen Health Physicians. The updated roadmap specifically focuses on driving brand elevation and executing national expansion initiatives across the United States. To spearhead this transition into the biologics and longevity sectors, the company appointed Dr. Ajit Dhaliwal as CEO, who brings a combination of medical expertise (MD) and an MBA degree. This pivot aims to capitalize on high-growth opportunities within advanced healthcare while diversifying the company's operational footprint. Analysts note that the integration of specialized medical leadership is a bold step toward enhancing long-term shareholder value. The market remains focused on the execution of these national growth plans under the new leadership team.